tirzepatide appetite Explained: The Future of Weight Management A new advancement in diabetes

Because semaglutide affects multiple systems in the body, it may indirectly influence mood

Lower BMI may show slower loss and earlier plateaus

Trying to find what your doctor said means scrolling through everything

This is metabolic health

Back to Journals Drug Design, Development and Therapy Volume 19 Semaglutide Alleviates Ovarian Oxidative Stress and Autophagy via the PI3K/AKT/mTOR Pathway in Mice with Polycystic Ovary Syndrome Authors Guo S, Li X, Liu M, Feng M, Wang X, Xue H , Zhang L Received 14 February 2025 Accepted for publication 5 May 2025 Published 23 May 2025 Volume 2025:19 Pages 42974310 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 3 Editor who approved publication: Dr Muzammal Hussain Sili Guo, * Xiaohan Li, * Mei Liu, Meiqi Feng, Xi Wang, Haibo Xue, Lei Zhang Department of Endocrinology and Metabolism, The First School of Clinical Medicine, Binzhou Medical University Hospital, Binzhou Medicial University, Binzhou, Shandong, Peoples Republic of China *These authors contributed equally to this work Correspondence: Lei Zhang, Department of Endocrinology and Metabolism, The First School of Clinical Medicine, Binzhou Medical University Hospital, Binzhou Medical University, Binzhou, Shandong, Peoples Republic of China, Email [email protected] Haibo Xue, Department of Endocrinology and Metabolism, The First School of Clinical Medicine, Binzhou Medical University Hospital, Binzhou Medical University, Binzhou, Shandong, Peoples Republic of China, Email [email protected] Background: Polycystic ovary syndrome (PCOS) is a typical reproductive endocrine system disease with high incidence rate among childbearing age women